| Period | 25 Jun 2022 → 28 Jun 2022 |
|---|---|
| Event type | Conference |
| Location | Athens, GreeceShow on map |
| Degree of Recognition | International |
Related content
-
Publications
-
In Vitro Inhibitory Effects and Mechanisms of Tyrosine Kinase Inhibitors on Warfarin Metabolism
Research output: Conference materials › Poster
-
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4 and CYP2C8, and inhibits CYP2D6 in vitro
Research output: Conference materials › Poster
-
In Vitro Inhibitory Effects andMechanisms of Tyrosine Kinase Inhibitors on Warfarin Metabolism
Research output: Conference materials › Abstract
-
Hydroxychloroquine is metabolized by CYP2D6, CYP3A4 and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A4 in vitro
Research output: Conference materials › Abstract